Has flibanserin revolutionized the treatment of hypoactive sexual desire disorder or is there still room for more effective therapeutics?

Rossella E. Nappi, Laura Cucinella, Lara Tiranini, Ellis Martini

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Pages (from-to)421-423
Number of pages3
JournalExpert Opinion on Pharmacotherapy
Issue number5
Publication statusPublished - Mar 24 2018


  • female sexual dysfunction (FSD)
  • flibanserin
  • hormone therapy (HT)
  • hypoactive sexual desire disorder (HSDD)
  • PDE5 inhibitors
  • psychoactive drugs
  • Sexual medicine

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this